The Silexan in the Treatment of Posttraumatic Stress Disorder (STOP) Trial - Protocol for a 12-Week Randomised Controlled Trial of Adjunctive Silexan for PTSD 24-Feb
Saliva Proteomics for the Diagnosis and Prognosis of Posttraumatic Stress Disorder (PTSD): Utilising the Advantage of Non-Invasive Sample Collection 18-Dec